chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: VARZOS
Symptoms: Blood glucose increased
Clinical narrative: Experiencing high blood sugars after receiving the shot; This case was reported by a consumer via interactive digital media and described the occurrence of blood sugar increased in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On 2nd June 2022, the patient received Shingrix. In June 2022, less than a week after receiving Shingrix, the patient experienced blood sugar increased. On an unknown date, the outcome of the blood sugar increased was not recovered/not resolved.   It was unknown if the reporter considered the blood sugar increased to be related to Shingrix.     Additional Information: GSK Receipt Date: 3-Jun-2022 Reporter's comments: This case was reported by the patient via interactive digital media. The patient received Shingrix on the day before the date of reporting. After vaccination, the patient experienced sudden high blood sugar levels post meals. The patient asked if this was known side effect or not. Additional Supportive Information: The follow-up would not possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Erythema
Clinical narrative: Shot 3 days ago is reddish after a shower.; This case was reported by a consumer via interactive digital media and described the occurrence of erythema in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   In June 2022, the patient received Shingles vaccine. In June 2022, less than a week after receiving Shingles vaccine, the patient experienced erythema. On an unknown date, the outcome of the erythema was unknown.   It was unknown if the reporter considered the erythema to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 04-JUN-2022 Reporter's Comment: This case was reported by the patient via interactive digital media. The patient had shingles shot 3 days ago and was reddish after a shower. The patient wanted to know what he/she could do about reddish after shingles shot. Additional Supportive Information: The follow up would not possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Incomplete course of vaccination, Social problem
Clinical narrative: I couldn't get my 2nd shot on time due to Covid; This case was reported by a consumer via interactive digital media and described the occurrence of social problem in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine (received 1st dose on an unknown date).   On an unknown date, the patient did not receive the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced social problem. On an unknown date, the outcome of the social problem was unknown.   Additional Information: GSK Receipt Date: 04-June-2022 Reporter's Comments: This case was reported by a patient via interactive digital media. The patient wanted to know how long could he/she wait to get 2nd shingles shot and it still be effective. The patient couldn't get the 2nd shot on time due to Covid. Additional Supportive Information: The follow-up would not be possible as no contact details were available.
Sex: U
Vaccine: VARZOS, VARZOS
Symptoms: Blister, Herpes zoster, Pain, Pruritus, Vaccination failure
Clinical narrative: I had the 2 shots/Shingles at the site of the 2nd injection/suspected vaccination failure; Shingles at the site of the 2nd injection; I had 3 holes in my arm at first just itched; Rash that blistered and finally they opened up; painful; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, pruritus, blister and pain. On an unknown date, the outcome of the vaccination failure, shingles, pruritus, blister and pain were unknown.   It was unknown if the reporter considered the vaccination failure, shingles, pruritus, blister and pain to be related to Shingles vaccine and Shingles vaccine.     Additional Information: GSK receipt date: 4-June-2022 Reporter's comment: This case was reported by a patient via interactive digital media. The patient had the 2 shots and did develop shingles at the site of the 2nd injection. The patient had 3 holes in arm. At first they just itched, then they blistered and finally they opened up. It was painful and I could imagine having a full blown case. Additional Supportive Information: This case was considered as suspected vaccination failure since the details regarding time to onset and laboratory confirmation of shingles was not provided.
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: My sister took the shot and then she got shingles/Suspected vaccination failure; Then she got shingles; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK receipt date: 4-June-2022 Reporter's comment: This case was reported by a patient's sibling via interactive digital media. The patient took shingles shot and she got shingles not longer after. Additional Supportive Information: This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles was not provided.
Sex: U
Vaccine: VARZOS
Symptoms: Burning sensation, Pain, Pruritus
Clinical narrative: itches; burns; painful; This case was reported by a consumer via interactive digital media and described the occurrence of itching in a 70-year-old patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced itching, burning sensation and pain. On an unknown date, the outcome of the itching, burning sensation and pain were not recovered/not resolved.   It was unknown if the reporter considered the itching, burning sensation and pain to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 03-JUN-2022 Reporter's Comments: This case was reported by a consumer via interactive digital media. The patient have had the shot and had been suffering for 3 weeks now. Itches, burns and was painful. Additional supportive information: No follow-up was possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: I get the Shingles shot. I had them a couple times/Suspected vaccination failure; I had shingles a couple times; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 04-JUN-2022 Reporter's Comments: This case was reported patient via interactive digital media. The patient got the Shingles shot and experienced  shingles a couple times. Additional supportive information: This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. The follow-up would not possible as no contact details were available.
Sex: F
Vaccine: VARZOS
Symptoms: Illness, Influenza like illness
Clinical narrative: both were sick, It was brutal; flu like symptoms; This case was reported by a consumer via interactive digital media and described the occurrence of sickness in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On 2nd June 2022, the patient received the 1st dose of Shingles vaccine. On 4th June 2022, 2 days after receiving Shingles vaccine, the patient experienced sickness and influenza-like symptoms. On an unknown date, the outcome of the sickness and influenza-like symptoms were unknown.   It was unknown if the reporter considered the sickness and influenza-like symptoms to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 05-JUN-2022 Reporter's Comments: The patient self-reported this case via interactive digital media. The patient received 1st dose of the 2 series shot on Thursday. The patient was sick with flu like symptoms on yesterday (day before reporting). The patient said hopefully the second shot was not bad. This was 1 of 2 linked cases, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022AMR089784:same reporter
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: I got the shot and a week later I got them; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 1 week after receiving Shingles vaccine, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 06-June-2022 Reporter's Comments: This case was reported by the patient via interactive digital media. The patient stated that he/she got the Shingles shot and a week later he/she got the shingles. Additional Supportive Information: The follow-up would not be possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Rhinorrhoea
Clinical narrative: clear runny nose; This case was reported by a consumer via interactive digital media and described the occurrence of runny nose in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced runny nose. On an unknown date, the outcome of the runny nose was unknown.   It was unknown if the reporter considered the runny nose to be related to Shingrix.     Additional Information: GSK Receipt Date: 05-JUN-2022 Reporter's Comments: This case was reported by a patient via interactive digital media. The patient received the dose of Shingrix vaccine and experienced side effects such as runny nose. The patient asked was clear runny nose common side effect. Additional supportive information: The follow-up would not possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Incomplete course of vaccination
Clinical narrative: Shingrix in August, but neglected a second dose; This case was reported by a consumer via interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included shingrix (1st dose received in August).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 05-Jun-2022 Reporter's Comments: The patient self-reported the case via interactive digital media. The reporter stated that we had a Shingrix vacation in August but neglected a second dose.  At the time of reporting, the reporter asked if it was still beneficial to get a second dose. Additional Supportive Information:  Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The follow-up would not possible as no contact details were available. This case is linked to the case US2022AMR089815, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022AMR089815:same report, other patient
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: Hubby suffered 6 times after shot/Suspected vaccination failure; Hubby had 6 times after shot; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 04-JUN-2022 Reporter's Comments: This case was reported patient's wife via interactive digital media. The patient suffered 6 times with shingles even after shot.  Additional supportive information: This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. This case had been linked to the case US2022AMR089766 reported by the same reporter. The follow-up would not possible as no contact details were available.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022AMR089766:Same Reporter
Sex: M
Vaccine: VARZOS
Symptoms: Illness, Influenza like illness
Clinical narrative: both were sick, It was brutal; flu like symptoms; This case was reported by a consumer via interactive digital media and described the occurrence of sickness in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On 2nd June 2022, the patient received the 1st dose of Shingles vaccine. On 4th June 2022, 2 days after receiving Shingles vaccine, the patient experienced sickness and flu like symptoms. On an unknown date, the outcome of the sickness and flu like symptoms were unknown.   It was unknown if the reporter considered the sickness and flu like symptoms to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 05-JUN-2022 Reporter's Comments: This case was reported by a consumer via interactive digital media. The reporter stated that the patient received 1st dose of the 2 series shot on Thursday. The patient was sick with flu like symptoms on yesterday (day before reporting). The reporter hopes that the second shot should not be as bad. This was 1 of 2 linked cases, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022AMR089772:same reporter
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: My husband has had the vaccines and once again had shingles/suspected vacccination failure; Once again had shingles; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK receipt date: 4-June-2022 Reporter's comment: This case was reported by a patient's wife via interactive digital media. The patient had the vaccines and once again had shingles. Additional Supportive Information: This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles was not provided.
Sex: U
Vaccine: VARZOS
Symptoms: Arthralgia
Clinical narrative: sore shoulder; This case was reported by a consumer via interactive digital media and described the occurrence of shoulder soreness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced shoulder soreness. On an unknown date, the outcome of the shoulder soreness was recovered/resolved.   It was unknown if the reporter considered the shoulder soreness to be related to Shingles vaccine.     Linked case(s) involving the same patient: US2022AMR089796   Additional Information: GSK Receipt Date: 05-JUN-2022 Reporter's Comments: This case was reported by a patient via interactive digital media. The patient received the dose of Shingles vaccine and only reaction the patient experienced was a sore shoulder for a couple of days. The patient reported that they said if you drink plenty of water throughout the day when you get it you did not have as many reactions really recommend getting it. Additional supportive information: For the tolerance of 2nd dose, refer linked case US2022AMR089796. The follow-up would not possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Arthralgia, Immune system disorder, Limb mass, Pain in extremity, Swelling
Clinical narrative: arm was sore; arm with a lump; immune system went in full alert; achy joints; This case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain in arm, local swelling, immune system disorder and joint pain. On an unknown date, the outcome of the pain in arm, local swelling, immune system disorder and joint pain were recovered/resolved.   It was unknown if the reporter considered the pain in arm, local swelling, immune system disorder and joint pain to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 04-JUN-2022 Reporter's Comment: This case was reported by a patient via interactive digital media. The patient's arm was sore with a lump for a couple of days and the day after the shot, his/her immune system went in full alert, so achy joints for a day, but that was it. Additional Supportive Information: The follow up would not possible, as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Arthralgia
Clinical narrative: sore shoulder; This case was reported by a consumer via interactive digital media and described the occurrence of shoulder soreness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine with an associated reaction of arthralgia (1st dose received on an unknown date refer case US2022AMR089793).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced shoulder soreness. Rechallenge with Shingles vaccine was positive. On an unknown date, the outcome of the shoulder soreness was recovered/resolved.   It was unknown if the reporter considered the shoulder soreness to be related to Shingles vaccine.     Linked case(s) involving the same patient:  US2022AMR089793   Additional Information: GSK Receipt Date: 05-JUN-2022 Reporter's Comments: This case was reported by a patient via interactive digital media. The patient received the dose of Shingles vaccine and only reaction the patient experienced was a sore shoulder for a couple of days. The patient reported that they said if you drink plenty of water throughout the day when you get it you did not have as many reactions really recommend getting it. Additional supportive information: The follow-up would not possible as no contact details were available.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022AMR089793:same report, other dose
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Pruritus, Vaccination failure
Clinical narrative: After the shots, experienced the shingles/Suspected vaccination failure; shingles; itching; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pruritus. On an unknown date, the outcome of the vaccination failure, shingles and pruritus were unknown.   It was unknown if the reporter considered the vaccination failure, shingles and pruritus to be related to Shingles vaccine.     Additional Information: GSK receipt date: 5-June-2022 Reporter's comment: This case was reported by a patient via interactive digital media. After having the shots 4 years ago, the patient experienced the shingles, no pain, But the itching had just about drove him/her crazy. The patient advised to get vaccinated. Additional Supportive Information: This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles was not provided.
Sex: U
Vaccine: VARZOS
Symptoms: Incomplete course of vaccination
Clinical narrative: Shingrix in August, but neglected a second dose; This case was reported by a consumer via interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included shingrix (1st dose received in August).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 05-Jun-2022 Reporter's Comments: The reporter reported the case via interactive digital media. The reporter stated that we (unspecified patients) had a Shingrix vaccination in August but neglected a second dose.  At the time of reporting, the reporter asked if it was still beneficial to get a second dose. Additional Supportive Information:  Till the time of reporting, the patients did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The follow-up would not possible as no contact details were available. This case is linked to the case US2022AMR089782, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022AMR089782:same report, other patient
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: got the vaccine, 2 years later got shingles/Suspected Vaccination failure; Got shingles; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 2 years after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 06-Jun-2022 Reporter's Comments: The patient self-reported the case via interactive digital media. The patient got the vaccine, 2 years later patient got the shingles. Additional Supportive Information: This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule and laboratory confirmation were unknown at the time of reporting. The follow-up would not possible as no contact details were available.
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: had shingles twice with the shot/ Suspected vaccination failure; had shingles twice with the shot; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 05-Jun-2022 Reporter's Comments: The case was reported by patient's child via interactive digital media. The patient had shingles twice with the shot. Additional Supportive Information:  This case was considered as suspected vaccination failure as details regarding completion of primary schedule, time to onset and laboratory confirmation for shingles were unknown at the time of reporting. The follow-up would not possible as no contact details were available.
Sex: U
Vaccine: VARZOS, VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: got two series of vaccine, still got shingles/ Suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.     Additional Information: GSK Receipt Date: 05-Jun-2022 Reporter's Comments: The patient self-reported the case via interactive digital media. The patient stated that although he/she got the two series of Shingles vaccine, still got shingles. Additional Supportive Information:  This case was considered as suspected vaccination failure as details regarding time to onset and laboratory confirmation shingles were unknown at the time of reporting. The follow-up would not possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: First outbreak 4 months ago, Just had second shot; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.  Additional Information: GSK Receipt Date: 05-JUN-2022 Reporter's Comment: This case was reported by a patient via interactive digital media. The patient had first outbreak of shingles 4 months before the date of reporting. The patient just had second shingles shot and he/she hoped for relief kind. Additional Supportive Information: The follow up would not possible as, no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Skin exfoliation
Clinical narrative: the skin on my back has a peeling; This case was reported by a consumer via interactive digital media and described the occurrence of peely skin in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced peely skin. On an unknown date, the outcome of the peely skin was not recovered/not resolved.   It was unknown if the reporter considered the peely skin to be related to Shingrix.     Additional Information: GSK Receipt Date: 6-JUN-2022 Reporter's Comment: The patient self-reported this case via interactive digital media. The patient's skin on back had a peeling since he/she had Shingrix. The patient asked if this was a common side effect. Additional supportive information: The follow-up would not possible, as no contact details were available.
Sex: F
Vaccine: VARZOS
Symptoms: Pruritus
Clinical narrative: Whole body started itching; This case was reported by a nurse via sales rep and described the occurrence of generalized pruritus in a elderly female patient who received Herpes zoster (Shingrix) (batch number kb97c, expiry date unknown) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, 2 days after receiving Shingrix, the patient experienced generalized pruritus. The patient was treated with hydrocortisone and benadryl (nos) (Benadryl). On an unknown date, the outcome of the generalized pruritus was recovered/resolved.   It was unknown if the reporter considered the generalized pruritus to be related to Shingrix.     Additional Information: GSK Receipt Date: 6-JUN-2022 Reporter's Comment: The patient received dose of Shingrix vaccine and 2 days after whole body was started itching.  Hydrocortisone and Benadryl didn't relieve.  The itching lasted 2 weeks. The reporter consented to follow-up.
Sex: U
Vaccine: VARZOS, VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: I was vaccinated twice and still got the shingles/suspected vaccination failure; Still got the shingles; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.     Additional Information: GSK receipt date: 6-June-2022 Reporter's comment: This case was reported by a consumer via interactive digital media. The patient was vaccinated twice and still got the shingles. The patient stated that he/she head that the shot only last 3 to 4 years. Additional Supportive Information: This case was considered as suspected vaccination failure since the details regarding time to onset and laboratory confirmation of shingles was not provided.
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: My cousin who had just gotten this shot. She broke out/Suspected vaccination failure; She broke out; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (Family History) (the patient's cousin and grandmother had shingles).   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK receipt date: 6-June-2022 Reporter's comment: This case was reported by a consumer via interactive digital media. The patient was reporter's cousin who had just gotten this shot and she broke out. The reporter got shingles once and his/her grandma did too. Additional Supportive Information: This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles was not provided.
Age: 84.0
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Patient was diagnosed with shingles 31-may-2022; This case was reported by a nurse via sales rep and described the occurrence of shingles in a 85-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 21st January 2022, the patient received the 1st dose of Shingrix. On 31st May 2022, 130 days after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.     Additional Information: GSK Receipt Date: 07-JUN-2022 Reporter's Comments: The patient was diagnosed with shingles on 31st May 2022. The patient had not received second dose. The reporter consented to follow-up.
Age: 55.0
Sex: F
Vaccine: VARZOS
Symptoms: Hypoaesthesia, Swollen tongue, Urticaria
Clinical narrative: hive on my chin; left side of tongue was a bit swollen; face numbness sensations; This case was reported by a consumer via call center representative and described the occurrence of hives in a 55-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 1st June 2022, the patient received the 1st dose of Shingrix. On 2nd June 2022, 1 days after receiving Shingrix, the patient experienced hives, swollen tongue and numbness facial. On an unknown date, the outcome of the hives, swollen tongue and numbness facial were recovered/resolved.   It was unknown if the reporter considered the hives, swollen tongue and numbness facial to be related to Shingrix.     Additional Information: GSK Receipt Date: 6-JUN-2022 Reporter's Comment: The patient experienced a hive on his/her chin and then also felt like left side of tongue was a bit swollen and some face numbness sensations. On an unknown date in June 2022, the outcome of the hives, swollen tongue and numbness facial were recovered/resolved. The patient would like to talk to someone to determine if it was safe for him/her to get 2nd dose. The reporter stated that she reported to her doctor but they seemed uncertain. The patient also stated that she laked with her doctor's office that day, but she thought it prudent to saw what GlaxoSmithKline may think since GlaxoSmithKline knew best probably how reactions had gone with others. The patient enquired even to knew if it might be better to take the 2nd dose closer to the 6 month mark rather than the 2 months in hopes if there were to be another experience it might remain mild. Additional supportive information:  The follow-up would not possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Hypoaesthesia, Swollen tongue, Urticaria
Clinical narrative: I developed a hive on my chin; Felt like left side of tongue was a bit swollen; Face numbness sensations; This case was reported by a consumer via interactive digital media and described the occurrence of hives in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On 1st June 2022, the patient received the 1st dose of Shingrix. On 2nd June 2022, 1 days after receiving Shingrix, the patient experienced hives, swollen tongue and numbness facial. On an unknown date, the outcome of the hives, swollen tongue and numbness facial were unknown.   It was unknown if the reporter considered the hives, swollen tongue and numbness facial to be related to Shingrix.     Additional Information: GSK Receipt Date: 6-JUN-2022 Reporter's Comment: The patient self-reported this case via interactive digital media. The patient received dose of Shingrix vaccine and experienced a hive on his/her chin and then also felt like left side of tongue was a bit swollen and some face numbness sensations. The patient would like to talk to someone to determine if it was safe for him/her to get 2nd dose. Additional supportive information: The follow-up would not possible as no contact details were available.
Sex: M
Vaccine: VARZOS
Symptoms: Inappropriate schedule of product administration
Clinical narrative: received vaccine on 5/27/22, then a second on 6/3/22; This case was reported by a other health professional via call center representative and described the occurrence of drug dose administration interval too short in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   Concomitant products included RECOMBINANT VARICELLA ZOSTER VIRUS SURFACE GLYCOPROTEIN E (SHINGRIX).   On 3rd June 2022, the patient received the 2nd dose of Shingrix. On 3rd June 2022, unknown after receiving Shingrix, the patient experienced drug dose administration interval too short. On an unknown date, the outcome of the drug dose administration interval too short was unknown.   Additional Information: GSK Receipt Date: 7-JUN-2022 Reporter's Comment: The patient received 1st dose of Shingrix vaccine on 27th May 2022 and 2nd dose on 3rd June 2022 from the pharmacy. The reporter asked what should they advise the patient to do. The reporter also asked should he still get another dose. Additional supportive information: The patient received 2nd dose of Shingrix vaccine earlier than the recommended interval, which led to shortening of vaccination schedule. The reporter consented to follow-up.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes virus infection
Clinical narrative: outbreak of herpes; This case was reported by a consumer via call center representative and described the occurrence of herpes virus infection in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On 5th December 2021, the patient received the 1st dose of Shingrix. On an unknown date, less than 9 months after receiving Shingrix, the patient experienced herpes virus infection. On an unknown date, the outcome of the herpes virus infection was not recovered/not resolved.   It was unknown if the reporter considered the herpes virus infection to be related to Shingrix.     Additional Information: Reporter's Comment: The reporter reported this case via interactive digital media. The patient received dose of Shingrix vaccine and experienced outbreak of herpes. The patient was at the 6 month mark for his/her second dose, but was experiencing an outbreak of herpes. The patient asked how long did he/she wait for second dose if had having an outbreak of herpes. The patient also asked how long did he/she need to wait and amp, was that ok for effectiveness. Additional supportive information: The follow-up would not possible, as no contact, details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: got vaccination, two weeks later had shingles; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 2 weeks after receiving Shingles vaccine, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 7-JUN-2022 Reporter's Comment: The patient self-reported this case via interactive digital media. The patient received dose of Shingles vaccine and then two weeks later experienced shingles. Additional supportive information: The follow-up would not possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Product supply issue
Clinical narrative: it wasn't available in my local pharmacy; This case was reported by a consumer via interactive digital media and described the occurrence of product supply issue in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 27th May 2018).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced product supply issue. On an unknown date, the outcome of the product supply issue was unknown.   Linked case(s) involving the same patient:  GB2022085933   Additional Information: GSK Receipt Date: 27-MAY-2022 and 8-June-2022 Reporter's Comments: The patient self-reported this case. The patient never got the second shot.  The patient stated that when it was time to take the second dose, it was not available in his/her local pharmacy. The patient's pharmacist suggested that he/she wrote to the manufacturer of the vaccine. The patient asked could he/she just did one more shot or did he/she have to do the 2 shot regimen 6 months apart. The patient's doctor did not know, and the pharmacist said he/she should contact GlaxoSmithKline.  The patient wanted to know do he/she need to take both shots again or just one more injection. Additional Supportive Information: When it was time to take the second dose, it was not available in his/her local pharmacy, which led to product supply issue. The case GB2022085933 was identified as duplicate of this case. The case GB2022085933 was deleted and all future correspondence would be added in the present case which stands as case of record for this patient.
Sex: U
Vaccine: VARZOS
Symptoms: Incomplete course of vaccination
Clinical narrative: It's been 2 years since my first shot didn´t get the 2nd; This case was reported by a consumer via interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on an unknown date 2 years ago).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK receipt date: 07-JUN-2022 Reporter's comment: The case was received from the consumer via interactive digital media. The patient enquired that its been 2 years since he/she received first Shingrix shot so he/she need to start the series from scratch.           Additional Supportive Information: Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. Follow-up could not be possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Incomplete course of vaccination
Clinical narrative: 3 years since first Shingrix shot; This case was reported by a consumer via interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (the patient received 1st Shingrix shot 3 years ago since the time of reporting).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 08-JUN-2022 Reporter's Comment: This case was reported by a patient via interactive digital media. The reporter asked if he/she should just get one more shot, or start over and get two more shots. Additional Supportive Information: Till the time of reporting, the patient did not receive the second dose of Shingrix , which led to incomplete course of vaccination. The follow up would not possible, as no contact details were available.
Sex: M
Vaccine: VARZOS
Symptoms: Chills, Cough, Inappropriate schedule of product administration, Pyrexia
Clinical narrative: Drug dose administration interval too long; Fever; Chills; Cough; This case was reported by a consumer via call center representative and described the occurrence of fever in a 57-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on an unknown date).   On 11th February 2022, the patient received the 2nd dose of Shingrix. On 11th February 2022, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the patient experienced fever, chills and cough. On an unknown date, the outcome of the fever, chills and cough were recovered/resolved and the outcome of the drug dose administration interval too long was unknown.   It was unknown if the reporter considered the fever, chills and cough to be related to Shingrix.     Additional Information: GSK Receipt Date: 01-JUN-2022 Reporter's Comments: The case was self reported by the patient. The patient reporter that it has been more than six since his first dose of Shingrix vaccine. The patient received his second dose of Shingrix vaccine and experienced fever, chills, and a cough that lasted about four months. AE (adverse event) filed. The patient reported that he was about to go on a trip and would probably wait until he returns next month and then get his second dose.  The reporter was given medical disclaimer. Referred to HCP (Health care professional). Spoke per PI (package insert) and content. Offered after call survey.  The reporter did not consent to follow up. Additional Supportive Information: The patient received the second dose later than the recommended interval, which led to lengthening of vaccination schedule.